Steven M Bair

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Stem Cell Transplantation

Hodgkin Lymphoma

Top Venues

American journal of hematology

University of Pennsylvania Health System

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Health System Jul 01 2017

United States

Clinical Fellow in Hematology/Oncology :: Division of Hematology/Oncology

Hospital of the University of Pennsylvania Jul 01 2015 - Jun 30 2017

United States

Resident in Internal Medicine :: Medicine

Hospital of the University of Pennsylvania Jul 01 2014 - Jun 30 2015

United States

Intern in Internal Medicine :: Medicine

Publications

Steven M Bair, Joshua D Brandstadter, Emily C Ayers, Edward A Stadtmauer
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy. Cancer 126 (9) (2020)
Steven M Bair, David L Porter
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia. American journal of hematology 94 (S1) (2019)
Steven M Bair, Lauren E Strelec, Tatyana A Feldman, Gulrayz Ahmed, Philippe Armand, Nirav N Shah, Arun N Singavi, Nishitha Reddy, Nadia Khan, Charalambos Andreadis, Khoan Vu, Scott F Huntington, Smith Giri, Chaitra Ujjani, Christina Howlett, Malik Faheem, Matthew R Youngman, Sunita D Nasta, Daniel J Landsburg, Stephen J Schuster, Jakub Svoboda
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. The oncologist 24 (7) (2018)
Steven M Bair, Lauren Strelec, Sarah J Nagle, Sunita D Nasta, Daniel J Landsburg, Anthony R Mato, Alison W Loren, Stephen J Schuster, Edward A Stadtmauer, Jakub Svoboda
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American journal of hematology 92 (9) (2017)